Clinical trials
Completed Phase 1/2 trials in Serbia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ablynx, a Sanofi company | 1 |
| Egetis Therapeutics | 1 |
| G1 Therapeutics, Inc. | 1 |
| Gemin X | 1 |
| Grifols Therapeutics LLC | 1 |
| Immatics Biotechnologies GmbH | 1 |
| Imugene Limited | 1 |
| Insmed Incorporated | 1 |
| Metropolitan University, Serbia | 1 |
| NeuTec Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Adenocarcinoma | 1 |
| Cystic Fibrosis | 1 |
| Fabry Disease | 1 |
| Fatigue | 1 |
| Febrile Neutropenia | 1 |
| Gastrointestinal Neoplasms | 1 |
| Gaucher Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.